Abstract
Abstract
Background
Cyproheptadine is an easily available over-the-counter first-generation antihistaminic that is often used as an appetite stimulant. Although it is usually a safe drug, rare instances of drug-induced liver injury may occur.
Case presentation
We report a case of cholestatic liver injury secondary to cyproheptadine in a young pharmacy student with chronic hepatitis B and review the literature of cyproheptadine-induced liver injury.
Conclusion
Although cyproheptadine is largely a safe drug, its potential for significant liver toxicity cannot be ignored.
Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Bertrand V, Massy N, Vegas N, Gras V, Chalouhi C, Tavolacci MP et al (2021) Safety of cyproheptadine, an orexigenic drug. Analysis of the French National Pharmacovigilance Data-Base and Systematic Review. Front Pediatr 9:712413
2. Chertoff J, Alam S, Clark V (2014) Cyproheptadine-induced acute liver failure. ACG Case Rep J 1(4):212–213
3. Larrey D, Geneve J, Pessayre D, Machayekhi JP, Degott C, Benhamou JP (1987) Prolonged cholestasis after cyproheptadine-induced acute hepatitis. J Clin Gastroenterol 9(1):102–104
4. Unchern S, Thithapandha A (1979) The effects of cyproheptadine hydroxhloride on hepatic drug-metabolizing enzymes in the rat. Drug Metab Dispos 7(6):411–415
5. Henry DA, Lowe JM, Donnelly T (1978) Jaundice during cyproheptadine treatment. BMJ 1(6115):753–753